MJD 2020 Publications

2020

  1. Lim S, Ku EJ, Lee SY, Lee JH, Lee J, Kim KM, Davies MJ.  Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study. BMJ Open Diabetes Res Care. 2020 Jan; 8(1). pii: e000807. doi: 10.1136/bmjdrc-2019-000807. PMID: 31958303
  2. Freemantle N, Mauricio D, Giaccari A, Bailey T, Roussel R, Franco D, Berthou B, Pilorget V, Wasterbacka J, Bosnyak Z, Bonnemaire M, Cali A, Nguyên-Pascal ML, Penfornis A, Perez-Maraver M, Seufert J, Sullivan SD, Wilding J, Wysham C, Davies MJ.  Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus. Curr Med Res Opin. 2020 Apr; 36(4):571-581. Doi: 10.1080/03007995.2019.1708287. Epub 2020 Jan 19. PMID: 31865758
  3. Henson J, Edwardson C, Celis-Morales C, Davies MJ, Dunstan D, Esliger D, Gill J, Kazi A, Khunti K, King J, McCarthy M, Sattar N, Stensel D, Velayudhan L, Zaccardi F, Yates T. Predictors of the acute postprandial response to breaking up prolonged sitting. Med Sci Sports Exerc. 2020 Feb 5. Doi: 10.1249/MSS.0000000000002249. [Epub ahead of print]. PMID: 31895295
  4. Baldry E, Davies MJ, Khunti K, Webb D.  Pragmatic management of low energy diets in people with Type 2 diabetes in primary care: a decision aid for clinicians. Diabet Med. 2020 May; 37(5):747-751. Doi: 10.1111/dme.14265. Epub 2020 Feb 20. PMID: 32020691
  5. Sathanapally H, Sidhu M, Fahami R, Gillies C, Kadam U, Davies MJ, Khunti K, Seidu S. Priorities of patients with multimorbidity and of clinicians regarding treatment and health outcomes: a systematic mixed studies review. BMJ Open. 2020 Feb 12; 10(2):e033445. Doi: 10.1136/bmjopen-2019-033445. PMID: 32051314
  6. Papamargaritis D, Al-Najim W, Lim JZM, Crane J, Lean M, le Roux C, McGowan B, O’Shea D, Webb D, Wilding J, Davies MJ. Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): Study protocol of an open-label, real-world, randomised, controlled trial. BMJ Open. 2020 Feb 13;10(2):e034137. Doi: 10.1136/bmjopen-2019-034137. PMID: 32060156
  7. Usman M, Gillies C, Davies MJ, Khunti K. Cost-effectiveness of intensive interventions compared to standard care in individuals with type 2 diabetes: A systematic review and critical appraisal of decision-analytic models.  Diabetes Res Clin Pract. 2020 Feb 12; 161:108073. Doi: 10.1016/j.diabres.2020.108073. [Epub ahead of print]. PMID: 32061637
  8. Lawson C, Zaccardi F, Squire I, Okhai H, Davies MJ, Huang W, Mamas M, Lam C, Khunti K, Khadam U.  Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity.  Circ Heart Fail. 2020 Feb;13(2):e006472. Doi: 10.1161/CIRCHEARTFAILURE.119.006472. Epub 2020 Feb 14. PMID: 32059630
  9. Munir F, Miller P, Biddle S, Davies MJ, Dunstan D, Esliger D, Gray L, O’Connell S, Yates T, Edwardson C.  A cost and cost-benefit analysis of the Stand More AT Work (SMArT Work) intervention. Int J Environ Res Public Health. 2020 Feb 13; 17(4). pii: E1214. Doi: 10.3390/ijerph17041214. PMID: 32070034
  10. Hussein H, Zaccardi F, Khunti K, Davies MJ, Patsko E, Dhalwani N, Kloecker D, Ioannidou E, Gray L.  Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis.  Diabetes Obes Metab. 2020 Jul; 22(7):1035-1046. Doi: 10.1111/dom.14008. Epub 2020 Mar 18. PMID: 32077218
  11. Woolley AK, Chudasama Y, Seidu S, Gillies C, Schreder S, Davies MJ, Khunti K.  Influence of sociodemographic characteristics on the preferred format of health education delivery in individuals with type 2 diabetes mellitus and or cardiovascular disease: a questionnaire study.  Diabet Med. 2020 Jun;37(6):982-990. Doi: 10.1111/dme.14275. Epub 2020 Mar 28. PMID: 32096573
  12. Jones P, James M, Davies MJ, Khunti K, Catt M. Yates T, Rowlands A, Mirkes E.  FilterK: a new outlier detection method to improve k-means cluster purity. J Biomed Inform. 2020 Apr; 104:103397. Doi: 10.1016/j.jbi.2020.103397. Epub 2020 Feb 26. PMID: 32113005
  13. Webb D, Htike ZZ, Swarbrick D, Brady E, Gray L, Biglands J, Gulsin G, Henson J, Khunti K, McCann G, Waller H, Webb M, Sargeant J, Yates T, Zaccardi F, Davies MJ. A randomized, open label, active comparator trial assessing the effects of 26 weeks of Liraglutide or Sitagliptin on cardiovascular function in young obese adults with Type 2 diabetes. Diabetes Obes Metab. 2020 Jul;22(7):1187-1196. Doi: 10.1111/dom.14023. Epub 2020 Apr 1. PMID: 32157772
  14. Huddlestone L, Turner J, Eborall H, Hudson N, Davies MJ, Martin G.  Application of normalisation process theory in understanding implementation processes in primary care settings in the UK: a systematic review. BMC Fam Pract. 2020 Mar 16;21(1):52. doi: 10.1186/s12875-020-01107-y. PMID: 32178624
  15. Kloecker D, Davies MJ, Khunti K, Zaccardi F. Uses and limitations of the restricted mean survival time: illustrative examples from cardiovascular outcomes and mortality trials in type 2 diabetes. Ann Intern Med. 2020 Mar 24. doi: 10.7326/M19-3286. [Epub ahead of print]. PMID: 32203984
  16. Henson J, Edwardson C, Davies MJ, Gill J, Heaney L, Khunti K, Ng L, Sattar N, Zaccardi F, Yates T.  Physical activity and lipidomics in a population at high risk of type 2 diabetes mellitus. J Sports Sci. 2020 May;38(10):1150-1160. ®doi: 10.1080/02640414.2020.1744836. Epub 2020 Mar 30. PMID: 32228122
  17. Hadjiconstantinou M, Dunkley A, Eborall H, Robertson N, Khunti K, Davies MJ.  Perceptions of Healthcare professionals and people with Type 2 diabetes on emotional support: a qualitative study.  BJGP Open. 2020 Mar 17. pii: bjgpopen20X101018. doi: 10.3399/bjgpopen20X101018. [Epub ahead of print]. PMID: 32184215
  18. Gulsin G, Swarbrick D, Athithan L, Brady E, Henson J, Baldry E, Argyridou S, Jaicim N, Squire G, Walters Y, Marsh A, McAdam J, Parke K, Biglands J, Yates T, Khunti K, Davies MJ, McCann G.  Effects of low-energy diet or exercise on cardiovascular function in working-age adults with type 2 diabetes: a prospective, randomized, open-label, blinded endpoint trial. Diabetes Care. 2020 Jun;43(6):1300-1310. doi: 10.2337/dc20-0129. Epub 2020 Mar 27. PMID: 32220917
  19. Zaccardi F, Davies MJ, Khunti K.  The present and future scope of real-world evidence research in diabetes: What questions can and cannot be answered and what might be possible in the future?  Diabetes Obes Metab. 2020 Apr;22 Suppl 3:21-34. doi: 10.1111/dom.13929. PMID: 32250528
  20. Del Prato S, Davies MJ, Bianchi C.  Use of incretin-based medications: What do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?  Metabolism. 2020 Apr 18:154242. doi: 10.1016/j.metabol.2020.154242. [Epub ahead of print]. PMID: 32315698
  21. Hadjiconstantinou M, Schreder S, Brough C, Northern A, Stribling B, Khunti K, Davies MJ.  Using intervention mapping to develop a digital self-management programme for people with type 2 diabetes: Tutorial on MyDESMOND.  J Med Internet Res. 2020 May 11;22(5):e17316. doi: 10.2196/17316. PMID: 32391797
  22. Ibrahim M, Davies MJ, Ahmad E, Annabi FA, Eckel R, Ba-Essa EB, El Sayed NA, Fischl A, Houeiss P, Iraqi H, Khochtali I, Khunti K, Masood S, Mimouni-Zerguini S, Shra S, Tuomilehto J, Umpierrez G.  Recommendations for Management of Diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD Consensus.  BMJ Open Diabetes Res Care. 2020 May;8(1). pii: e001248. doi: 10.1136/bmjdrc-2020-001248. PMID: 32366501
  23. Davies MJ, Kloecker D, Webb D, Khunti K, Zaccardi F.  Number needed to treat in cardiovascular outcome trials with glucagon-like peptide-1 receptor agonists: A systematic review with temporal analysis.  Diabetes Obes Metab. 2020 May 6. doi: 10.1111/dom.14066. [Epub ahead of print]. PMID: 32372425
  24. Pearsey H, Henson J, Sargeant J, Davies MJ, Khunti K, Suzuki T, Bowden-Davies K, Cuthbertson D, Yates T. Zinc-alpha2-glycoprotein, dysglycaemia and insulin resistance: a systematic review and meta-analysis Rev Endocr Metab Disord. 2020 May 7. doi: 10.1007/s11154-020-09553-w. [Epub ahead of print]. PMID: 32377863
  25. Biddle S, O’Connell S, Davies MJ, Dunstan D, Edwardson C, Esliger D, Gray L, Yates T, Munir F.  Reducing sitting at work: process evaluation of the SMArT Work (Stand More AT Work) intervention.  Trials. 2020 May 13;21(1):403. doi: 10.1186/s13063-020-04300-7.  PMID: 32404181
  26. Khunti K, Davies MJ, Seidu S.  Cardiovascular outcome trials of glucose lowering therapies.  Expert Rev Pharmacoecon Outcomes Res. 2020 May 13;1-13. doi: 10.1080/14737167.2020.1763796. Online ahead of print. PMID: 32403956
  27. Ahmad E, Davies MJ, Khunti K.  Rapid Review: Diabetic retinopathy screening during the COVID-19 pandemic.  https://www.cebm.net/covid-19/rapid-review-diabetic-retinopathy-screening-during-the-covid-19-pandemic/, May 12 2020 online.
  28. Yates T, Razieh C, Zaccardi F, Davies MJ, Khunti K.  Obesity and risk of COVID-19: analysis of UK Biobank.  Prim Care Diabetes. 2020 May 28;S1751-9918(20)30196-0. doi: 10.1016/j.pcd.2020.05.011. Online ahead of print. PMID: 32493608
  29. Willis A, Winston C, Gray L, Dallosso H, Waheed G, Davies MJ, Seidu S, Khunti K.  Effects of an electronic software ‘prompt’ with healthcare professional training on cardiovascular and renal complications in a multi-ethnic population with Type 2 Diabetes and Microalbuminuria (The GP Prompt study): results of a pragmatic cluster-randomised trial.  Diabetes Care. 2020 Aug;43(8):1893-1901. doi: 10.2337/dc19-2243. Epub 2020 May 19. PMID: 32430457
  30. Buse J, Wexler D, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio D, Davies MJ. Correction To: 2019 Update To: Management of Hyperglycaemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).  Diabetologia. 2020 May 15. doi: 10.1007/s00125-020-05151-2. Online ahead of print. PMID: 32409867
  31. Kushner R, Calanna S, Davies MJ, Dicker D, Garvey T, Goldman B, Lingvay I, Thomsen M, Wadden T, Wharton S, Wilding J, Rubino D.  Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity (Silver Spring). 2020 Jun;28(6):1050-1061. doi: 10.1002/oby.22794. PMID: 32441473
  32. Vounzoulaki E, Khunti K, Abner S, Tan BK, Davies MJ, Gillies C.  Progression to type 2 diabetes in women with a known history of gestational diabetes: A systematic review and meta-analysis.  BMJ. 2020 May 13;369:m1361. doi: 10.1136/bmj.m1361. PMID: 32404325
  33. Davies MJ, Kristunas C, Huddlestone L, Alshreef A, Bodicoat D, Dixon S, Eborall H, Glab A, Hudson N, Khunti K, Martin G, Northern A, Patterson M, Pritchard R, Schreder S, Stribling B, Turner J, Gray LJ.  Increasing uptake of structured self-management education programmes for type 2 diabetes in a primary care setting: A feasibility study.  Pilot Feasibility Stud. 2020 May 22;6:71. doi: 10.1186/s40814-020-00606-0. eCollection 2020. PMID: 32477589
  34. Sargeant J, Brady E, Zaccardi F, Tippins F, Webb D, Aroda V, Gregg E, Khunti K, Davies MJ.  Adults with early-onset type 2 diabetes (aged 18 to 39 years) are severely under-represented in diabetes clinical research trials.  Diabetologia. 2020 Jun 2. doi: 10.1007/s00125-020-05174-9. Online ahead of print. PMID: 32483683
  35. Vounzoulaki E, Khunti K, Tan BK, Davies MJ, Gillies C.  Gestational diabetes: screening uptake, current challenges and the future – a focused review.  Br J Diabetes 2020;20:9-14, https://doi.org/10.15277/bjd.2020.236.
  36. Chudasama Y, Gillies C, Appiah K, Zaccardi F, Razieh C, Davies MJ, Yates T, Khunti K.  Multimorbidity and SARS-CoV-2 Infection in UK Biobank.  Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5) (2020) 775-776, https://doi.org/10.1016/j.dsx.2020.06.003. PMID : 32526625
  37. Dalsgaard EM, Sandbæk A, Griffin S, Rutten GEHM, Khunti K, Davies MJ, Irving G, Vos R, Webb D, Wareham N, Witte D.  Patient-reported outcomes after ten-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: The ADDITION-Europe trial.  Diabet Med. 2020 Jun 12. doi: 10.1111/dme.14342. Online ahead of print. PMID: 32530523
  38. Athithan L, Chowdhary A, Swarbrick D, Gulsin G, Singh A, Jex N, Jain M, Khan J, Graham-Brown M, Wormleighton J, Parke K, Davies MJ, Karamitsos T, Clarke K, Neubauer S, Levelt E, McCann G.  Male sex adversely affects the phenotypic expression of diabetic heart disease.  Ther Adv Endocrino Metab.  2020 May 27;11:2042018820927179. doi: 10.1177/2042018820927179. eCollection 2020. PMID: 32523675
  39. McCarthy M, Yates T, Webb D, Game F, Gray L, Davies MJ.  The health impacts of seated arm ergometry training in patients with a Diabetic Foot Ulcer: Protocol for a Randomised Controlled Trial.  BMJ Open.   2020 Jun 21;10(6):e039062. doi: 10.1136/bmjopen-2020-039062. PMID: 32565482
  40. Razieh C, Zaccardi F, Davies MJ, Khunti K, Yates T.  Body Mass Index and Risk of COVID-19 Across Ethnic Groups: Analysis of UK Biobank Study.  Diabetes Obes Metab. 2020 Jun 29. doi: 10.1111/dom.14125. Online ahead of print. PMID: 32602268
  41. Levene L, Coles B, Davies MJ, Hanif W, Zaccardi F, Khunti K.  COVID-19 cumulative mortality rates for frontline healthcare staff in England. Br J Gen Pract. 2020 Jun 25;70(696):327-328. doi: 10.3399/bjgp20X710837. Print 2020 Jul. PMID: 32586803
  42. Khunti K, Singh AK, Gillies C, Singh R, Singh A, Chudasama Y, Coles B, Seidu S, Zaccardi F, Davies MJ.  Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A Systematic Review and Meta-analysis.  Diabetes Obes Metab. 2020 Jun 23. doi: 10.1111/dom.14124. Online ahead of print. PMID: 32573903
  43. Chudasama Y, Gillies C, Zaccardi F, Coles B, Davies MJ, Seidu S, Khunti K.  Impact of COVID-19 on Routine Care for Chronic Diseases: A global survey of views from healthcare professionals.  Diabetes Metab Syndr. 2020 Jun 23;14(5):965-967. doi: 10.1016/j.dsx.2020.06.042. Online ahead of print. PMID: 32604016
  44. Buse J, Wexler D, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio D, Davies MJ. Erratum. 2019 Update To: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:487-493.  Published Erratum, Diabetes Care. 2020 Jul;43(7):1670. doi: 10.2337/dc20-er07. Epub 2020 May 22. PMID: 32444453
  45. Herring R, Shojaee-Moradie F, Garesse R, Stevenage M, Jackson N, Fielding B, Mendis A, Johnsen S, Umpleby M, Davies MJ, Russell-Jones D.  Metabolic effects of an SGLT2 inhibitor (dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes.  Diabetes Care. 2020 Sep;43(9):2128-2136. doi: 10.2337/dc19-2579. Epub 2020 Jul 8. PMID: 32641376
  46. Gulsin G, Henson J, Brady E, Sargeant J, Wilmot E, Athithan L, Htike ZZ, Marsh AM, Biglands J, Kellman P, Khunti K, Webb D, Davies MJ, Yates T, McCann G.  Cardiovascular determinants of aerobic exercise capacity in adults with type 2 diabetes. Diabetes Care. 2020 Sep;43(9):2248-2256. doi: 10.2337/dc20-0706. Epub 2020 Jul 17. PMID: 32680830
  47. Matthews D, Wysham C, Davies MJ, Slee A, Alba M, Lee M, Perkovic V, Mahaffey KW, Neal B.  Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program. Diabetes Obes Metab. 2020 Jul 20. doi: 10.1111/dom.14143. Online ahead of print. PMID: 32691499
  48. Byrne J, Dallosso H, Rogers S, Gray L, Waheed G, Patel P, Gupta P, Doherty Y, Davies MJ, Khunti K.  Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial. BMC Med. 2020 Jul 27;18(1):198. doi: 10.1186/s12916-020-01664-0. PMID: 32713349
  49. Yates T, Zaccardi F, Razieh C, Gillies C, Rowlands A, Kloecker D, Chudasama Y, Davies MJ, Khunti K.  Framework to aid analysis and interpretation of ongoing COVID-19 research.  Wellcome Open Research 2020, 5:208. doi.org/10.12688/wellcomeopenres.16227.1.
  50. Ling S, Brown K, Miksza J, Howells L, Morrison A, Issa E, Yates T, Khunti K, Davies MJ, Zaccardi F.  Association of type 2 diabetes with cancer: A meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people.  Diabetes Care. 2020 Sep;43(9):2313-2322. doi: 10.2337/dc20-0204. PMID: 32910779
  51. Zaccardi F, Ling S, Lawson C, Davies MJ, Khunti K.  Severe hypoglycaemia and absolute risk of cause-specific mortality in subjects with type 2 diabetes: A UK primary care observational study. Diabetologia. 2020 Oct;63(10):2129-2139. doi: 10.1007/s00125-020-05223-3. Epub 2020 Jul 30. PMID: 32728893
  52. Plekhanova T, Rowlands A, Yates T, Hall A, Brady E, Davies MJ, Khunti K, Edwardson C. Equivalency of sleep estimates: comparison of three research-grade accelerometers. Journal for the Measurement of Physical Behaviour, Ahead of print, DOI: https://doi.org/10.1123/jmpb.2019-0047.
  53. Mickute M, Henson J, Rowlands A, Sargeant J, Webb D, Hall A, Edwardson C, Baldry E, Brady E, Khunti K, Davies MJ, Yates T.  Device-measured physical activity and its association with physical function in adults with type 2 diabetes mellitus.  Diabet Med. 2020 Aug 26. doi: 10.1111/dme.14393. Online ahead of print. PMID: 32844472
  54. Dawkins N, Yates T, Edwardson C, Maylor B, Davies MJ, Dunstan D, Highton P, Herring L, Khunti K, Rowlands A.  Comparing 24 h physical activity profiles: office workers, women with a history of gestational diabetes and people with chronic disease condition(s).  Journal of Sports Sciences online 25 August 2020, doi.org/10.1080/02640414.2020.1812202.
  55. Martin C, Jenkins D, Minhas J, Gray L, Tang J, Williams C, Sze S, Pan D, Jones W, Verma R, Knapp S, Major R, Davies MJ, Brunskill N, Wiselka M, Brightling C, Khunti K, Haldar P, Pareek M.  Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: results from an observational cohort study. EClinicalMedicine. 2020 Jul 17;100466. doi: 10.1016/j.eclinm.2020.100466. Online ahead of print. PMID: 32840492
  56. Fitzpatrick C, Gillies C, Seidu S, Kar D, Ioannidou E, Davies MJ, Patel P, Gupta P, Khunti K.  Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and meta-analysis. BMJ Open. 2020 Jul 23;10(7):e036575. doi: 10.1136/bmjopen-2019-036575. PMID: 32709649
  57. Henson J, Rowlands A, Baldry E, Brady E, Davies MJ, Edwardson C, Yates T, Hall A.  Physical behaviors and chronotype in people with Type 2 diabetes. BMJ Open Diabetes Res Care. 2020 Jul;8(1):e001375. doi: 10.1136/bmjdrc-2020-001375. PMID: 32675292
  58. Pritchard R, Brady E, Chudasama Y, Davies MJ, McCann G.  Perceptions of Risk of Attending Hospital During the COVID-19 Pandemic: A UK Public Opinion Survey. Research Square, doi.org/10.21203/rs.3.rs-72263/v1.
  59. Rowlands A, Davies MJ, Dempsey P, Edwardson C, Razieh C, Yates T.  Wrist-worn accelerometers: recommending ~1.0 m g as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults.  Br J Sports Med. 2020 Sep 14;bjsports-2020-102293. doi: 10.1136/bjsports-2020-102293. Online ahead of print. PMID: 32928741
  60. Usman M, Khunti K, Davies MJ, Gillies C.  Association and relative importance of multiple risk factor control on cardiovascular disease, end-stage renal disease and mortality in people with type 2 diabetes: a population-based retrospective cohort study.  Prim Care Diabetes. 2020 Aug 27;S1751-9918(20)30244-8. doi: 10.1016/j.pcd.2020.08.008. Online ahead of print. PMID: 32863149
  61. Zaccardi F, Jacquot E, Cortese V, Tyrer F, Seidu S, Davies M, Khunti K. Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes.  Diabetes Obes Metab. 2020 Aug 5. doi: 10.1111/dom.14169. Online ahead of print. PMID: 32761768
  62. Khunti K, Davies MJ, Marx N, Buse N.  Draft FDA guidance for assessing the safety of glucose lowering therapies: a missed opportunity? Lancet Diabetes Endocrinol. 2020 Oct;8(10):810-811. doi: 10.1016/S2213-8587(20)30302-8. PMID: 32946819
  63. Ling S, Brown K, Miksza J, Howells L, Morrison A, Issa E, Yates T, Khunti K, Davies MJ, Zaccardi F.  Risk of cancer incidence and mortality associated with diabetes: a systematic review with trend analysis of 203 cohorts.  Nutrition, Metabolism and Cardiovascular Diseases, Available online 25 September 2020. doi.org/10.1016/j.numecd.2020.09.023.
  64. Pearsey H, Henson J, Sargeant J, Webb D, Gill J, Celis C, Suzuki T, Waller H, Khunti K, Ng L, Boweden-Davies K, Cuthbertson D, Jackson A, Davies MJ, Yates T.  Dysglycaemia and South Asian ethnicity: A proteomic discovery and confirmation analysis highlights differences in ZAG. J Proteins Proteom (2020). https://doi.org/10.1007/s42485-020-00046-7.
  65. Cumming S, Harrington D, Davies MJ, Edwardson C, Gorely T, Khunti K, Rowlands A, Yates T, Sherar L.  Maturational timing, physical self-perceptions and physical activity in UK Adolescent females: Investigation of a mediated effects model.  Ann Hum Biol. 2020 Jun;47(4):384-390. doi: 10.1080/03014460.2020.1784277. PMID: 32996817
  66. Coles B, Zaccardi F, Hvid C, Davies MJ, Khunti K.  Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: a real world study of patients followed up to 19 years.  Diabetes Obes Metab. 2020 Oct 7. doi: 10.1111/dom.14218. Online ahead of print. PMID: 33026165
  67. Inzucchi S, Davies MJ, Khunti K, Trivedi P, George J, Zwiener I, Johansen OE, Sattar N.  Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes.  Diabetes Obes Metab. 2020 Oct 20. doi: 10.1111/dom.14234. Online ahead of print. PMID: 33084149
  68. Coles B, Khunti K, Booth S, Zaccardi F, Davies MJ, Gray L. Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data.  BMJ Open. 2020 Oct 23;10(10):e037937. doi: 10.1136/bmjopen-2020-037937. PMID: 33099496
  69. Sargeant J, Jelleyman C, Coull N, Edwardson C, Henson J, King J, Khunti K, McCathy M, Rowlands A, Stensel D, Waller H, Webb, Davies MJ, Yates T.  Improvements in Glycemic Control After Acute Moderate-Intensity Continuous or High-Intensity Interval Exercise Are Greater in South Asians Than White Europeans With Nondiabetic Hyperglycemia: A Randomized Crossover Study. Diabetes Care. 2020 Nov 6;dc201393.  doi: 10.2337/dc20-1393.  Online ahead of print. PMID:  33158948
  70. Zaccardi F, Khunti K, Marx N, Davies MJ.  First line treatment for type 2 diabetes: Is it too early to abandon Metformin?  Lancet. 2020 Nov 28;396(10264):1705-1707. doi: 10.1016/S0140-6736(20)32523-X. PMID: 33248483
  71. Chan J, Lim LL, Wareham N, Shaw J, Orchard T, Zhang P, Lau E, Eliasson B, Kong A, Ezzati M, Aguilar-Salinas C, McGill M, Levitt N, Ning G, So WY, Adams J, Bracco P, Forouhi N, Gregury G, Guo J, Hua X, Klatman E, Magliano D, Ng BN, Ogilvie D, Panter J, Pavkov M, Shao H, Unwin N, White M, Wou C, Ma R, Schmidt M, Ramachandran A, Seino Y, Bennett P, Oldenburg B, Gagliardion J, Luk A, Clarke P, Ogle G, Davies MJ, Holman R, Gregg E.  The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.  Lancet. 2021 Dec 19;396(10267):2019-2082. doi: 10.1016/S0140-6736(20)32374-6. Epub 2020 Nov 12. PMID: 33189186
  72. Marx N, Davies MJ, Grant P, Mathieu C, Petrie J, Cosentino F, Buse J.  Guideline recommendations and the positioning of newer drugs in type 2 diabetes care.  Lancet Diabetes Endocrinol. 2021 Jan;9(1):46-52. doi: 10.1016/S2213-8587(20)30343-0. Epub 2020 Nov 4. PMID: 33159841.  Erratum in Correction to Lancet Diabetes Endocrinol 2021; 9: 46-52.  Lancet Diabetes Endocrinol. 2021 Jan;9(1):e1. doi: 10.1016/S2213-8587(20)30407-1. PMID: 33338417
  73. Jones P, Bus S, Davies MJ, Khunti K, Webb D.  Toe gaps and their assessment in footwear for people with diabetes: a narrative review.  J Foot Ankle Res. 2020 Dec 4;13(1):70. doi: 10.1186/s13047-020-00439-3. PMID: 33276804
  74. Seidu S, Gillies C, Farooqi A, Trivedi H, Than T, Brady E, Davies MJ, Khunti K.  A cost comparison of an enhanced primary care diabetes service and standard care.  Prim Care Diabetes. 2020 Dec 2;S1751-9918(20)30296-5. doi: 10.1016/j.pcd.2020.10.011. Online ahead of print. PMID: 33279438
  75. Ahmad E, Sargeant J, Zaccardi F, Khunto K, Webb D, Davies MJ.  Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?  Pharmaceuticals (Basel). 2020 Nov 27;13(12):E427. doi: 10.3390/ph13120427. PMID: 33261058
  76. Argyridou S, Bernieh D, Henson J, Edwardson C, Davies MJ, Khunti K, Suzuki T, yates T.  Associations between physical activity and Trimethylamine N-oxide in those at risk of Type 2 Diabetes. BMJ Open Diabetes Res Care. 2020 Dec; 8(2):e001359. doi: 10.1136/bmjdrc-2020-001359. PMID: 33262105
  77. Plekhanova T, Rowlands A, Davies MJ, Edwardson C, Hall A, Yates T. Effect of exercise on sleep and bi-directional associations with accelerometer-assessed physical activity in men with obesity.  Appl Physiol Nutr Metab. 2020 Nov 30. Doi: 10.1139/apnm-2020-0361. Online ahead of print. PMID: 33252989
  78. Jones P, Davies MJ, Khunti K, Fong D, Webb D. In-shoe pressure thresholds for people with diabetes and neuropathy at risk of ulceration: A systematic review. J Diabetes Complications. 2020 Nov 26; 107815. Doi: 10.1016/j.jdiacomp.2020.107815. Online ahead of print. PMID: 33280984
  79. Coles B, Zaccardi F, Ling S, Davies MJ, Samani N, Khunti K.  Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi-ethnic population. J Diabetes Investig. 2020 Nov 18. Doi: 10.1111/jdi.13464. Online ahead of print. PMID: 33206469
  80. Highton P, Hadjiconstantinou M, Schreder S, Davies MJ, Khunti K. COVID-19, ethnicity and cardiometabolic disease self-management in UK primary care. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14 (2020) 2241e2243. doi.org/10.1016/j.dsx.2020.11.013.
  81. Dibato J, Montvida O, Zaccardi F, Sargeant J, Davies MJ, Khunti K, Paul S. Association of Cardiometabolic Multimorbidity and Depression With Cardiovascular Events in Early-Onset Adult Type 2 Diabetes: A Multiethnic Study in the U.S. Diabetes Care. 2020 Nov 11; dc202045. Doi: 10.2337/dc20-2045. Online ahead of print. PMID: 33177170
  82. Zaccardi F, Kloecker D, Buse J, Mathieu C, Khunti K, Davies MJ. Use of Metformin and Cardiovascular Effects of New Classes of Glucose Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes. Diabetes Care. 2020 Dec 17; dc202080. Doi: 10.2337/dc20-2080. Online ahead of print. PMID: 33334809
  83. Quinn L, Davies MJ, Northern A, Brough C, Schreder S, Stribling B, Khunti K, Hadjiconstantinou M.  Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic. Diabet Med. 2020 Dec 4; e14469. Doi: 10.1111/dme.14469. Online ahead of print. PMID: 33274489
  84. Rowlands A, Kloecker D, Chudasama Y, Davies MJ, Dawkins N, Gillies C, Khunti K, Razieh C, Islam N, Zaccardi F, Yates T. Association of timing and balance of physical activity and rest/sleep with risk of COVID-19: A UK Biobank study. Mayo Clin Proc. 2021 Jan; 96(1):156-164. Doi: 10.1016/j.mayocp.2020.10.032. Epub 2020 Oct 31. PMID: 33413813

 

Share this page:

Navigation

shanghairanking-sm.jpg